The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 31, 2015
Filed:
Jan. 21, 2010
Applicants:
Nathalie Guibourt, Barcelona, ES;
Alberto Ortega Munoz, Barcelona, ES;
Julio Castro-palomino Laria, Barcelona, ES;
Inventors:
Nathalie Guibourt, Barcelona, ES;
Alberto Ortega Munoz, Barcelona, ES;
Julio Castro-Palomino Laria, Barcelona, ES;
Assignee:
Oryzon Genomics, S.A., Barcelona, ES;
Primary Examiner:
Int. Cl.
CPC ...
C07C 211/40 (2006.01); C07D 213/38 (2006.01); C07C 217/58 (2006.01); C07C 217/74 (2006.01); C07C 255/58 (2006.01); C07D 213/61 (2006.01); C07D 277/28 (2006.01); C07D 333/20 (2006.01); C07D 333/28 (2006.01);
U.S. Cl.
CPC ...
C07D 213/38 (2013.01); C07C 211/40 (2013.01); C07C 217/58 (2013.01); C07C 217/74 (2013.01); C07C 255/58 (2013.01); C07D 213/61 (2013.01); C07D 277/28 (2013.01); C07D 333/20 (2013.01); C07D 333/28 (2013.01); C07C 2101/02 (2013.01);
Abstract
The present invention relates to phenylcyclopropylamine derivatives. In particular, pharmaceutical compositions comprising phenylcyclopropylamine derivatives are provided. The compounds of this invention can, inter alia, be used for the treatment and the prevention of cancer as well as neurodegenerative diseases or disorders.